RT Journal Article
SR Electronic
T1 Walking Pace, Sport Genes, and the Lung Cancer
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.10.02.23296383
DO 10.1101/2023.10.02.23296383
A1 Wang, Mengying
A1 Meng, Xiangqi
A1 Tian, Weiliang
A1 Sun, Ruinan
A1 Wang, Siyue
A1 Qin, Yilei
A1 Ranson, Janice M.
A1 Peng, Hexiang
A1 Napolioni, Valerio
A1 Lau, Patrick W. C.
A1 Wu, Tao
A1 Huang, Jie
YR 2023
UL http://medrxiv.org/content/early/2023/11/01/2023.10.02.23296383.abstract
AB Background To investigate the association between walking pace and lung cancer risk, and explore whether any association is modified by endurance and power-related genes.Methods We followed up 449,890 UK Biobank participants free of cancer at baseline. Data on self-reported walking pace were collected by touchscreen questionnaire at baseline. Blood samples were obtained for genotyping. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated for lung cancer incidence and mortality, with slow walking pace as the reference.Findings 4,087 lung cancer incident cases and 2,245 lung cancer deaths were identified during a median follow-up period of 12.1 and 12.7 years, respectively. For incident lung cancer, HR (95% CI) were 0.71 (0.65- 0.78) and 0.55 (0.49-0.61) among participants with steady and brisk walking pace, respectively. For lung cancer mortality, steady and brisk walking paces were associated with 32% and 48% lower risks, respectively. Associations of walking pace with risks of lung cancer occurrence and mortality were modified by rs1815739 in ACTN3 and rs7191721 in RBFOX1. The protective effect of faster walking pace was more evident among participants carrying a higher number of T allele for rs1815739 in ACTN3 (Pinteraction=0.04 for both lung cancer incidence and mortality) and A allele for rs7191721 in RBFOX1 (Pinteraction=0.01 for lung cancer incidence, Pinteraction=0.004 for lung cancer mortality).Interpretation Faster walking pace is associated with lower risks of both lung cancer occurrence and mortality, and this protective effect is modulated by polymorphisms in endurance gene RBFOX1 and in power gene (ACTN3).Funding This work was supported by grants from the China Postdoctoral Science Foundation (Grant No. BX2021021, 2022M710249), Fujian Provincial Health Technology Project (Grant No. 2020CXB009), and the Natural Science Foundation of Fujian Province, China (Grant No. 2021J01352).Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by grants from the China Postdoctoral Science Foundation (Grant No. BX2021021, 2022M710249), Fujian Provincial Health Technology Project (Grant No. 2020CXB009), and the Natural Science Foundation of Fujian Province, China (Grant No. 2021J01352).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of the National Information Governance Board for Health and Social Care and the National Health Service North West Multi-Centre Research Ethics Committee gave ethical approval for this work(Ref 11/NW/0382).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at UK Biobank (https://www.ukbiobank.ac.uk/). https://www.ukbiobank.ac.uk/